Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $350.75 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $81.95 | 4 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $39.90 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $37.79 | 2 | $0 (2023) |
| ABBVIE INC. | $33.98 | 2 | $0 (2023) |
| PFIZER INC. | $28.83 | 2 | $0 (2019) |
| Chiesi USA, Inc. | $24.59 | 1 | $0 (2021) |
| Covidien LP | $24.42 | 1 | $0 (2019) |
| Allergan Inc. | $23.17 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.06 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $17.29 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $53.32 | 3 | AstraZeneca Pharmaceuticals LP ($37.79) |
| 2022 | $62.96 | 3 | Alexion Pharmaceuticals, Inc. ($39.90) |
| 2021 | $60.33 | 3 | Chiesi USA, Inc. ($24.59) |
| 2019 | $91.87 | 5 | Merck Sharp & Dohme Corporation ($27.95) |
| 2018 | $25.76 | 1 | Merck Sharp & Dohme Corporation ($25.76) |
| 2017 | $56.51 | 4 | Merck Sharp & Dohme Corporation ($28.24) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/22/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Rare Disease | ||||||
| 05/12/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Rare Disease | ||||||
| 01/11/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Rare Disease | ||||||
| 09/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: DIABETES | ||||||
| 06/10/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Rare Disease | ||||||
| 08/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2021 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $24.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/12/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/09/2019 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: VACCINE | ||||||
| 01/31/2019 | Covidien LP | INVOS (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Cerebral/Somatic Oximetry | ||||||
| 08/10/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: VACCINE | ||||||
| 10/12/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/12/2017 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2017 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: VACCINE | ||||||
| 06/13/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 945 | 1,013 | $1.9M | $116,859 |
| 2022 | 5 | 1,105 | 1,187 | $2.2M | $139,785 |
| 2021 | 10 | 1,044 | 1,150 | $1.9M | $136,517 |
| 2020 | 10 | 911 | 1,004 | $1.6M | $115,084 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 506 | 555 | $1.1M | $71,582 | 6.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 293 | 306 | $419,039 | $25,985 | 6.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 105 | 110 | $292,380 | $17,148 | 5.9% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 41 | 42 | $38,640 | $2,144 | 5.5% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 679 | 746 | $1.5M | $99,663 | 6.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 275 | 287 | $393,190 | $25,859 | 6.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 62 | 62 | $164,796 | $10,101 | 6.1% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 77 | 80 | $73,476 | $4,035 | 5.5% |
| G0168 | Wound closure utilizing tissue adhesive(s) only | Facility | 2022 | 12 | 12 | $7,920 | $126.63 | 1.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 620 | 670 | $1.4M | $93,343 | 6.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 205 | 209 | $286,146 | $19,456 | 6.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 56 | 56 | $148,848 | $9,739 | 6.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 68 | 69 | $63,356 | $3,830 | 6.0% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 17 | 27 | $12,906 | $2,676 | 20.7% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2021 | 14 | 22 | $20,735 | $2,375 | 11.5% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2021 | 17 | 30 | $19,706 | $1,643 | 8.3% |
| 64495 | Injections of lower or sacral spine facet joint using imaging guidance, third and any additional level(s) | Facility | 2021 | 17 | 27 | $6,534 | $1,605 | 24.6% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2021 | 17 | 27 | $6,534 | $1,587 | 24.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 13 | 13 | $3,570 | $262.57 | 7.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 508 | 546 | $1.1M | $72,471 | 6.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 178 | 182 | $236,775 | $16,303 | 6.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 62 | 62 | $155,496 | $10,648 | 6.8% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2020 | 29 | 48 | $32,064 | $3,720 | 11.6% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2020 | 18 | 29 | $26,455 | $3,372 | 12.7% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 19 | 26 | $12,428 | $2,722 | 21.9% |
About Stacy Richardson, D.O., E.D.D
Stacy Richardson, D.O., E.D.D is a Emergency Medicine healthcare provider based in Jonesboro, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891968293.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacy Richardson, D.O., E.D.D has received a total of $350.75 in payments from pharmaceutical and medical device companies, with $53.32 received in 2023. These payments were reported across 19 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($350.75).
As a Medicare-enrolled provider, Richardson has provided services to 4,005 Medicare beneficiaries, totaling 4,354 services with total Medicare billing of $508,244. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Anesthesiology
- Location Jonesboro, AR
- Active Since 04/07/2008
- Last Updated 10/18/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1891968293
Products in Payments
- ANDEXXA (Biological) $77.69
- DALVANCE (Drug) $57.15
- GARDASIL (Biological) $41.68
- PNEUMOVAX 23 (Biological) $25.76
- CLEVIPREX (Drug) $24.59
- INVOS (Device) $24.42
- JARDIANCE (Drug) $23.06
- XARELTO (Drug) $17.29
- ELIQUIS (Drug) $16.33
- Kcentra (Biological) $15.77
- BRIDION (Drug) $14.51
- CHANTIX (Drug) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Jonesboro
Mr. Dirk Rainwater, Md, MD
Emergency Medicine — Payments: $8,181
Stacy Wilbanks, Md, MD
Emergency Medicine — Payments: $1,458
Lynn Flowers, Md, MD
Emergency Medicine — Payments: $787.49
Dr. Mickey Deel, D.o, D.O
Emergency Medicine — Payments: $236.94
Danny Grubbs, M.d, M.D
Emergency Medicine — Payments: $168.82
Uchenna Aguwa, Do, DO
Emergency Medicine — Payments: $168.59